These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 8067753)
21. Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative. Slater EE; MacDonald JS Drugs; 1988; 36 Suppl 3():72-82. PubMed ID: 3076125 [TBL] [Abstract][Full Text] [Related]
22. The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells. Glynn SA; O'Sullivan D; Eustace AJ; Clynes M; O'Donovan N BMC Cancer; 2008 Jan; 8():9. PubMed ID: 18199328 [TBL] [Abstract][Full Text] [Related]
23. Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase induce reductase accumulation and altered lamellar bodies in rat forestomach keratinocytes. Singer II; Kawka DW; Scott S; Bailey P; Kloss MW; Majka J; MacDonald JS Arterioscler Thromb; 1991; 11(5):1156-65. PubMed ID: 1911702 [TBL] [Abstract][Full Text] [Related]
24. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 9. The synthesis and biological evaluation of novel simvastatin analogs. Hartman GD; Halczenko W; Duggan ME; Imagire JS; Smith RL; Pitzenberger SM; Fitzpatrick SL; Alberts AW; Bostedor R; Chao YS J Med Chem; 1992 Oct; 35(21):3813-21. PubMed ID: 1433193 [TBL] [Abstract][Full Text] [Related]
25. Action of lovastatin, simvastatin, and pravastatin on sterol synthesis and their antiproliferative effect in cultured myoblasts from human striated muscle. van Vliet AK; Nègre-Aminou P; van Thiel GC; Bolhuis PA; Cohen LH Biochem Pharmacol; 1996 Nov; 52(9):1387-92. PubMed ID: 8937448 [TBL] [Abstract][Full Text] [Related]
27. Effect of simvastatin, an inhibitor of hydroxy-methylglutaryl coenzyme A reductase, on the growth of human Ito cells. Mallat A; Preaux AM; Blazejewski S; Dhumeaux D; Rosenbaum J; Mavier P Hepatology; 1994 Dec; 20(6):1589-94. PubMed ID: 7982659 [TBL] [Abstract][Full Text] [Related]
28. Hemoglobin catabolism and the killing of intraerythrocytic Plasmodium falciparum by chloroquine. Orjih AU; Ryerse JS; Fitch CD Experientia; 1994 Jan; 50(1):34-9. PubMed ID: 8293798 [TBL] [Abstract][Full Text] [Related]
29. Effects of dipyridamole on Plasmodium falciparum-infected erythrocytes. Akaki M; Nakano Y; Ito Y; Nagayasu E; Aikawa M Parasitol Res; 2002 Dec; 88(12):1044-50. PubMed ID: 12444453 [TBL] [Abstract][Full Text] [Related]
30. Stage-dependent effects of chloroquine on Plasmodium falciparum in vitro. Yayon A; Vande Waa JA; Yayon M; Geary TG; Jensen JB J Protozool; 1983 Nov; 30(4):642-7. PubMed ID: 6198514 [TBL] [Abstract][Full Text] [Related]
31. Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells. Sivaprasad U; Abbas T; Dutta A Mol Cancer Ther; 2006 Sep; 5(9):2310-6. PubMed ID: 16985065 [TBL] [Abstract][Full Text] [Related]
32. Plasma concentration profiles of simvastatin 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitory activity in kidney transplant recipients with and without ciclosporin. Arnadottir M; Eriksson LO; Thysell H; Karkas JD Nephron; 1993; 65(3):410-3. PubMed ID: 8289991 [TBL] [Abstract][Full Text] [Related]
33. Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways. Baumeister S; Wiesner J; Reichenberg A; Hintz M; Bietz S; Harb OS; Roos DS; Kordes M; Friesen J; Matuschewski K; Lingelbach K; Jomaa H; Seeber F PLoS One; 2011 May; 6(5):e19334. PubMed ID: 21573242 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of sustained/controlled-release dosage forms of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors in dogs and humans. Cheng H; Sutton SC; Pipkin JD; Zentner GM; Rogers JD; Schwartz JI; Mitchel YB; Grasing K; Schwartz MS; Amin RD Pharm Res; 1993 Nov; 10(11):1683-7. PubMed ID: 8290485 [TBL] [Abstract][Full Text] [Related]
35. Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo. Germershausen JI; Hunt VM; Bostedor RG; Bailey PJ; Karkas JD; Alberts AW Biochem Biophys Res Commun; 1989 Feb; 158(3):667-75. PubMed ID: 2493245 [TBL] [Abstract][Full Text] [Related]
36. Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal rats. Joles J; Willekes-Koolschijn N; Koomans H; Van Tol A; Geelhoed-Mieras T; Crommelin D; Van Bloois L; Krajnc-Franken M; Cohen L; Griffioen M Lab Anim; 1992 Oct; 26(4):269-80. PubMed ID: 1447905 [TBL] [Abstract][Full Text] [Related]
37. Effects of simvastatin, a cholesterol synthesis inhibitor, on phosphatidylcholine synthesis in HepG2 cells. Yanagita T; Yamamoto K; Ishida S; Sonda K; Morito F; Saku K; Sakai T Clin Ther; 1994; 16(2):200-8. PubMed ID: 8062316 [TBL] [Abstract][Full Text] [Related]